Intranasal delivery of HMGB1 siRNA confers target gene knockdown and robust neuroprotection in the postischemic brain

被引：0
|
作者：
Lee, J-K. [1 ]
Kim, I-D. [1 ]
Pak, I-S. [1 ]
Han, P-L. [2 ]
机构：
[1] Inha Univ, Sch Med, Dept Anat, Inchon, South Korea
[2] Ewha Womans Univ, Div Nano Sci & Brain Dis, Res Inst, Seoul, South Korea
来源：
FEBS JOURNAL | 2013年 / 280卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：346 / 346
页数：1
相关论文
共 31 条
  • [21] A HMGB-1 siRNA delivery using brain-targeting ligand embedded exosomes for ischemic stroke therapy
    Kim, M.
    Kim, G.
    Oh, J.
    Lee, Y.
    Lee, M.
    FEBS OPEN BIO, 2018, 8 : 119 - 119
  • [22] Molecular and Thermodynamic Studies on DNA Triplex Formed in the Promoter Region of HMGB1 Gene as a Selective Target for Anticancer Drugs
    Neelam, Lohani
    Rajeswari, Moganty R.
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2017, 17 (12) : 1698 - 1709
  • [23] miR-548b Suppresses Melanoma Cell Growth, Migration, and Invasion by Negatively Regulating Its Target Gene HMGB1
    Feng, Xi-en
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2021, 36 (02) : 189 - 201
  • [24] One SNP in the 3'-UTR of HMGB1 gene affects the binding of target bta-miR-223 and is involved in mastitis in dairy cattle
    Li, Liming
    Huang, Jinming
    Zhang, Xiaojian
    Ju, Zhihua
    Qi, Chao
    Zhang, Yan
    Li, Qiuling
    Wang, Changfa
    Miao, Weiran
    Zhong, Jifeng
    Hou, Minghai
    Hang, Suqin
    IMMUNOGENETICS, 2012, 64 (11) : 817 - 824
  • [25] One SNP in the 3′-UTR of HMGB1 gene affects the binding of target bta-miR-223 and is involved in mastitis in dairy cattle
    Liming Li
    Jinming Huang
    Xiaojian Zhang
    Zhihua Ju
    Chao Qi
    Yan Zhang
    Qiuling Li
    Changfa Wang
    Weiran Miao
    Jifeng Zhong
    Minghai Hou
    Suqin Hang
    Immunogenetics, 2012, 64 : 817 - 824
  • [26] Potential mechanisms of microRNA-141-3p to alleviate chronic inflammatory pain by downregulation of downstream target gene HMGB1: in vitro and in vivo studies
    Shen, W-S
    Xu, X-Q
    Zhai, N-N
    Zhou, Z-S
    Shao, J.
    Yu, Y-H
    GENE THERAPY, 2017, 24 (06) : 353 - 360
  • [27] Potential mechanisms of microRNA-141-3p to alleviate chronic inflammatory pain by downregulation of downstream target gene HMGB1: in vitro and in vivo studies
    W-S Shen
    X-Q Xu
    N-N Zhai
    Z-S Zhou
    J Shao
    Y-H Yu
    Gene Therapy, 2017, 24 : 353 - 360
  • [28] Intravenous Delivery of AAV Gene Therapy Provides Broad SOD1 Knockdown in the Spinal Cord and Robust Efficacy in a Mouse Model of SOD1-ALS
    Grannan, Michael D.
    Sayed-Zahid, Ambreen
    Hefferan, Michael
    Nonnenmacher, Mathieu
    Grant, Shaoyong Li Kyle
    Pande, Nilesh
    Tyson, Katherine
    Laguna-Torres, Jessenia
    Kulkarni, Anupriya
    Kaufman, James
    Clement, Joe
    Thompson, Jeffrey
    Sah, Dinah W. Y.
    Patzke, Holger
    MOLECULAR THERAPY, 2022, 30 (04) : 495 - 495
  • [29] Intraparenchymal Spinal Cord Delivery of AAV Gene Therapy Provides Robust SOD1 Knockdown in Large Mammal Spinal Cord for the Treatment of SOD1-ALS
    Patzke, Holger
    Chen, Qingmin
    Carroll, Jenna
    Wang, Ruo-Jie
    Zhou, Pengcheng
    Huang, Carol
    Aubin, Justin
    Nonnenmacher, Mathieu
    Ren, Xiao
    Wang, Wei
    Christensen, Emily
    Johnson, Brianna
    Liu, Li
    Tam Nguyen
    Zhou, Ruohong
    Hossbach, Markus
    Deckert, Jochen
    Chen, Fen
    Thompson, Jeff
    Federici, Thais
    Boulis, Nicholas M.
    Hou, Jay
    Sah, Dinah
    MOLECULAR THERAPY, 2019, 27 (04) : 20 - 20
  • [30] Robust SOD1 knockdown in large mammal spinal cord using a novel delivery paradigm with AAV gene therapy targeting SOD1 for the treatment of SOD1-ALS
    Patzke, H.
    Chen, Q.
    Carroll, J.
    Wang, R.
    Zhou, P.
    Huang, C.
    Wang, X.
    Aubin, J.
    Nonnenmacher, M.
    Ren, X.
    Wang, W.
    Christensen, E.
    Johnson, B.
    Liu, L.
    Nguyen, T.
    Zhou, R.
    Hossbach, M.
    Deckert, J.
    Chen, F.
    Thompson, J.
    Federici, T.
    Boulis, N. M.
    Hou, J.
    Sah, D.
    HUMAN GENE THERAPY, 2018, 29 (12) : A81 - A82
1234